Preclinical Substance development is a crucial/vital/essential step in the journey to bringing new therapies to market. Successful/Effective/Efficient drug candidates must demonstrate a favorable pharmacokinetic/absorption/metabolism and excretion profile (DMPK) before progressing to clinical trials. This is where preclinical DMPK services play a p